ARTIDIS ^None

ARTIDIS is a company that has developed a nanomechanical sensor capable of differentiating between benign and malignant tissue in less than three hours. The technology also allows clinicians to accurately determine the aggressiveness of a tumor based on the nanomechanical signature of cells. The company's nano-probe measures the physical properties of tissue, allowing for the discovery of nano-mechanical biomarkers and predicting disease development. The technology is not limited to cancer and can be applied to any living tissue for a broad range of research and development applications.